| P2093 | author name string | Osamu Shimozato | |
| | Naohiko Anzai | |
| | Takehiko Kamijo | |
| | Kan Chiba | |
| | Tomomi Furihata | |
| | Yuchen Sun | |
| | Hidetaka Akita | |
| | Manami Harada | |
| | Yoshihiro Nabeya | |
| | Nobuhiro Takiguchi | |
| | Hiroaki Souda | |
| P2860 | cites work | Exosomes: the future of biomarkers in medicine | Q38138606 |
| | Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator | Q38472815 |
| | Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer | Q38997796 |
| | Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines | Q39132939 |
| | A cancer-specific variant of the SLCO1B3 gene encodes a novel human organic anion transporting polypeptide 1B3 (OATP1B3) localized mainly in the cytoplasm of colon and pancreatic cancer cells | Q39231842 |
| | Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells | Q39397857 |
| | Investigation of free cancer cells in peripheral blood using CEA mRNA expression in perioperative colorectal cancer patients | Q41920225 |
| | Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. | Q45947940 |
| | Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. | Q51502354 |
| | RNA biomarkers in colorectal cancer. | Q54286948 |
| | Cytoplasmic poly(A) binding protein 4 is highly expressed in human colorectal cancer and correlates with better prognosis. | Q55056571 |
| | Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 |
| | Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up | Q57758169 |
| | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 |
| | Discovery and Validation of Hypermethylated Markers for Colorectal Cancer | Q28277670 |
| | Systematic review of microsatellite instability and colorectal cancer prognosis | Q28303189 |
| | Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives | Q33211152 |
| | Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. | Q33913309 |
| | Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma | Q34083336 |
| | Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer | Q34899360 |
| | Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers | Q34983690 |
| | Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients | Q34998496 |
| | Circulating exosomal microRNAs as biomarkers of colon cancer. | Q35140085 |
| | American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer | Q35806164 |
| | Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization | Q36467712 |
| | A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors | Q36502335 |
| | Identification and characterization of ANO9 in stage II and III colorectal carcinoma | Q36557295 |
| | Blood markers for early detection of colorectal cancer: a systematic review | Q36968878 |
| | Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin. | Q37411227 |
| | Single immunochemical fecal occult blood test for detection of colorectal neoplasia. | Q37447039 |
| | PIK3CA in Colorectal Cancer | Q37612390 |
| | Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. | Q37669854 |
| P921 | main subject | colorectal cancer | Q188874 |
| | biomarker | Q864574 |
| P577 | publication date | 2017-06-08 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Cancer-type OATP1B3 mRNA has the potential to become a detection and prognostic biomarker for human colorectal cancer. | |